Konig Laboratorium CHOLESTATIN contains 10 mg of Monacolin K, a natural ingredient approved in the European Union for lowering blood cholesterol.
Monascus purpureus also known as red yeast rice has been traditionally used in China for hundreds of years as a spice added to foods. Only in the 20th century it was discovered that the Chinese did not suffer from high cholesterol due to the consumption of this spice. Monascus purpureus contains a natural substance called Monacolin K. In September 2011, European Food Safety Authority (EFSA) approved a health claim for Monacolin K extracted from Monascus purpureus as a natural cholesterol management dietary supplement in a concentration of 10 mg per dose1.
Monacolin K is a safe and efficient ingredient as a possible natural substitute for synthetic statins. Clinical studies indicate that depending on the degree of dyslipidemia a dosage of 10 mg Monacolin K once or twice a day is safe and sufficient 2,3,4.
CHOLESTATIN is approved in the European Union.
No side effects reported.
References:
- Scientific Opinion on the substantiation of health claims related to Monacolin K from red yeast rice and maintenance of normal blood LDL-cholesterol concentrations (ID 1648, 1700) pursuant to Article 13(1) of Regulation (EC) No 1924/2006; EFSA Journal 2011;9(7):2304
- Cheng-Chieh Lin et al.; Clinical Study on the Efficacy and safety of Monascus purpureus Went rice in subjects with hyperlipidemia; European Journal of Endocrinology (2005) 153 679–686
- Jianping Liu ; Chinese red yeast rice (Monascus purpureus) for primary hyperlipidemia: a meta-analysis of randomized controlled trials; Chinese Medicine 2006, 1:4
- David J. Becker et al.; Red Yeast Rice for Dyslipidemia in Statin-Intolerant Patients, A Raddomized Trial; Annals of Internal Medicicne 2009;150:830-839
Features
- Capsules per container: 30
- Capsule shell: Vegetable gelatin
- Bottle size: 100 cc
- Active ingredient dosage per capsule: Monacolin K: 10 mg
- Organic / Vegan / Dairy Free / Gluten Free / Soy Free
There are no reviews yet.